{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:09:04Z","timestamp":1784592544740,"version":"3.55.0"},"reference-count":77,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Gr\u00fcnenthal Group"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2021,1,2]]},"DOI":"10.1080\/03007995.2020.1832977","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T08:32:17Z","timestamp":1602232337000},"page":"89-100","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Safety of tapentadol compared with other opioids in chronic pain treatment: network meta-analysis of randomized controlled and withdrawal trials"],"prefix":"10.1080","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3759-1508","authenticated-orcid":false,"given":"R.","family":"Freynhagen","sequence":"first","affiliation":[{"name":"Department of Anaesthesiology, Critical Care Medicine, Pain Medicine & Palliative Care, Benedictus Krankenhaus Tutzing, Pain Center Lake Starnberg, Academic Teaching Hospital Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"},{"name":"Department of Anaesthesiology, Klinikum Rechts der Isar, Technische Universit\u00e4t M\u00fcnchen, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Elling","sequence":"additional","affiliation":[{"name":"Gr\u00fcnenthal GmbH, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Radic","sequence":"additional","affiliation":[{"name":"Gr\u00fcnenthal GmbH, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sohns","sequence":"additional","affiliation":[{"name":"Gr\u00fcnenthal GmbH, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liedgens","sequence":"additional","affiliation":[{"name":"Gr\u00fcnenthal GmbH, Aachen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"James","sequence":"additional","affiliation":[{"name":"Quantics Biostatistics, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"McCool","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"York Health Economics Consortium, York, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1002\/ejp.970"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.2174\/187447370801150611184218"},{"key":"CIT0003","volume-title":"Pathways to prevention workshop: the role of opioids in the treatment of chronic pain","author":"National Institutes of Health","year":"2014"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1464"},{"key":"CIT0005","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins JPT","year":"2011"},{"key":"CIT0006","unstructured":"Khan KS, Ter Riet G, Glanville J, et\u00a0al. Undertaking systematic reviews of research on effectiveness: CRD\u2019s guidance for those carrying out or commissioning reviews. 2nd ed. York (UK): Centre for Reviews and Dissemination (CRD); 2001. (CRD Report 4)."},{"key":"CIT0007","unstructured":"Centre for Reviews and Dissemination [Internet]. PROSPERO. York (UK): CRD; 2011. [Cited 2015 June 29]. Available from: http:\/\/www.crd.york.ac.uk\/PROSPERO\/"},{"key":"CIT0008","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins JPT","year":"2011"},{"key":"CIT0009","volume-title":"Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee","author":"Australian Government Department of Health and Aging","year":"2008"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-4356(97)00049-8"},{"key":"CIT0011","volume-title":"NICE DSU technical support document 2: a generalised linear modelling framework for pairwise and network meta-analysis of randomized controlled trials","author":"Dias S","year":"2011"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.08.012"},{"key":"CIT0013","volume-title":"NICE DSU technical support document 4: Inconsistency in networks of evidence based on randomized controlled trials","author":"Dias S","year":"2011"},{"key":"CIT0014","unstructured":"European Patients\u2019 Academy (EUPATI) [Internte]. Clinical trial designs. Brussels (Belgium): European Patients\u2019 Forum (EPF); 2015 [updated 2015 November 23; cited 2020 January]. Available from: https:\/\/www.eupati.eu\/clinical-development-and-trials\/clinical-trial-designs\/#Withdrawal_trials"},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2009.00342.x"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-014-0204-3"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.04.008"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1097\/01.ajp.0000146215.86038.38"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aeu056"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2007.0015"},{"issue":"3","key":"CIT0021","first-page":"764","volume":"27","author":"Peloso PM","year":"2000","journal-title":"J Rheumatol"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2012.00555.x"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2015.1047747"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0885-3924(02)00383-4"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.2165\/11533440-000000000-00000"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.2165\/00044011-200727010-00007"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2003.11.006"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2010.497720"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2012.02.028"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw097"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X115595"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2007.05.016"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2005.00057.x"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.12807"},{"key":"CIT0035","volume-title":"Placebo-controlled trial with OROS hydromorphone hydrochloride to treat patients with moderate to severe pain induced by osteoarthritis of the hip or the knee","author":"Janssen-Cilag International NV","year":"2008"},{"key":"CIT0036","volume-title":"A long-term safety study with tapentadol ER and oxycodone CR in patients with moderate to severe pain due to chronic, painful diabetic peripheral neuropathy (DPN)","author":"Johnson & Johnson Pharmaceutical Research & Development LLC","year":"2010"},{"key":"CIT0037","volume-title":"An efficacy and safety study for tapentadol extended release (JNS024ER) in chronic pain participants","author":"Janssen Pharmaceutical","year":"2010"},{"key":"CIT0038","volume-title":"A phase 2 study of tapentadol extended-release (JNS024ER)) in Japanese participants with chronic pain due to diabetic neuropathic pain or postherpetic neuralgia","author":"Janssen Pharmaceutical","year":"2010"},{"issue":"3","key":"CIT0039","doi-asserted-by":"crossref","first-page":"155","DOI":"10.5055\/jom.2006.0025","volume":"2","author":"Rauck RL","year":"2006","journal-title":"J Opioid Manag"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1335189"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.04.035"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1111\/j.1533-2500.2010.00397.x"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.831816"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2006.09.011"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12377"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2015.0304"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S83930"},{"issue":"4","key":"CIT0048","doi-asserted-by":"crossref","first-page":"329","DOI":"10.36076\/ppj.2014\/17\/329","volume":"17","author":"Kress HG","year":"2014","journal-title":"Pain Physician"},{"key":"CIT0049","volume-title":"Efficacy and safety of hydrocodone bitartrate (HYD) in subjects with moderate to severe chronic low back pain","author":"Purdue Pharma LP","year":"2011"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2015.993573"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.484723"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2006.11.017"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2011.0062"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000670"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X162692"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000000315"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1128307"},{"issue":"3","key":"CIT0058","first-page":"772","volume":"27","author":"Schnitzer TJ","year":"2000","journal-title":"J Rheumatol"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2010.537589"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2291"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2008.0013"},{"key":"CIT0062","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S179110"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2011.611494"},{"key":"CIT0064","unstructured":"World Health Organization. Impact of impaired access to controlled medications. Geneva (Switzerland): WHO; 2020 [Cited 2020 August 21]. Available from: https:\/\/www.who.int\/medicines\/areas\/quality_safety\/Impaired_Access\/en\/"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1186\/s40634-019-0204-6"},{"key":"CIT0066","author":"Rian T","year":"2020","journal-title":"Pain"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02209-x"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-018-0778-x"},{"key":"CIT0069","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S160255"},{"issue":"7","key":"CIT0070","first-page":"1672","volume":"21","author":"Coluzzi F","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"CIT0071","doi-asserted-by":"publisher","DOI":"10.1177\/2049463716657363"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1626"},{"key":"CIT0073","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.5.587"},{"key":"CIT0074","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aei210"},{"key":"CIT0075","unstructured":"Gov.uk [Internet]. Tapentadol (Palexia): risk of seizures and reports of serotonin syndrome when co-administered with other medicines. London (UK): Government Digital Service; 2019 [updated 2019 January 09; cited 2020 January 03]. Available from: https:\/\/www.gov.uk\/drug-safety-update\/tapentadol-palexia-risk-of-seizures-and-reports-of-serotonin-syndrome-when-co-administered-with-other-medicines"},{"key":"CIT0076","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-017-0654-0"},{"key":"CIT0077","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.18472"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2020.1832977","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T11:47:55Z","timestamp":1649850475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2020.1832977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1,2]]}},"alternative-id":["10.1080\/03007995.2020.1832977"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2020.1832977","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-05-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-28","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-09-20","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-13","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}